Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01263873
Other study ID # 04-10-05
Secondary ID
Status Completed
Phase N/A
First received December 17, 2010
Last updated December 2, 2014
Start date November 2010
Est. completion date May 2011

Study information

Verified date December 2014
Source University Hospital Case Medical Center
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of the study is to determine if there are differences related to ease of intubation reported by clinicians who use the Parker Flex-Tip® endotracheal tubes(ETT)compared to the standard Mallinckrodt® (ETT). The problem is two (ETTs), the Parker Flex-Tip® and the Mallinckrodt®, are currently available for use in operative suites for intubation, but few studies have compared these devices with each other. Two research questions to be answered in the study are 1. Is there a difference in the ease of intubation when the Parker Flex-Tip® (ETT) is used when compared to the standard Mallinckrodt® (ETT)? and 2. Are there differences in the number of successful intubations when comparing the Parker Flex-Tip® (ETT) and the standard Mallinckrodt® (ETT)? The hypotheses are the use of the Parker Flex-Tip® (ETT) will demonstrate: 1. Fewer seconds to intubate the trachea. 2. Higher self-reported ease of placement scores and 3. Fewer redirections to intubate the trachea. The number of successful intubations is expected to be the same in both arms of the study.


Description:

There are not many different types of (ETT)s with different ends or tips. The standard (ETT) by Mallinckrodt® is a disposable polyvinyl chloride plastic tube that has one hooded Murphy tip eye at the end of the tube. The Murphy tip eye is to help with ventilation and air passage if the main end is occluded with mucus or a foreign body. Another type of (ETT) is the Parker Flex-Tip® (ETT), which has a soft flex-tip that is configured to pass easily through the airway anatomy and has two Murphy tip eyes. Currently there are no published data comparing the Parker Flex-Tip® (ETT) with standard Mallinckrodt® (ETT) when the GlideScope® is used. The data are limited concerning the ease of intubation when using the Parker Flex-Tip® (ETT). The study is a two-factor randomized block intervention study design. Subjects assigned to the first group will be intubated using the standard Mallinckrodt® (ETT). The subjects assigned to the second group will be intubated using the Parker Flex-Tip® (ETT). Randomization will be accomplished using the sealed envelope technique. There are six anesthesia providers who will be using ETTs to intubate. A block design will be used to make sure each anesthesia provider receives the same number of patients randomized to the Mallinckrodt and to the Parker Flex-Tip® (ETT)s.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 2011
Est. primary completion date May 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

1. Subjects that are males and non-pregnant females > or equal to 18 years of age that require a general anesthetic with an (ETT).

2. Able to give informed consent (adults, English reading and speaking)

Exclusion Criteria:

1. Any subject on examination with a mallampati III or greater and/or history of difficult intubation.

2. Any subject with an American Society of Anesthesiologist classification greater than 3.

3. Any subject needing rapid sequence induction.

4. Any subject that the anesthesia provider considers the GlideScope® to be contraindicated.

5. Any subject that an anesthesia provider feels for any reason at any time is not appropriate for inclusion in this study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)


Related Conditions & MeSH terms


Intervention

Device:
Mallinckrodt (ETT)
7.0 millimeter internal diameter for female 8.0 millimeter internal diameter for male
Parker Flex-Tip (ETT)
7.0 millimeter internal diameter for female 8.0 millimeter internal diameter for male

Locations

Country Name City State
United States University Hospitals of Cleveland Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Case Medical Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ease of Intubation, as Measured by Time in Seconds for ETT Insertion To measure the ease of intubation by time in seconds for ETT insertion. Time was measured in seconds and started when the anesthesia provider asked for the ETT and stopped once the ETT was placed through the glottis. The time was obtained from video recordings during the intubation by the principal investigator (PI). Participants were followed for the duration of intubation, an average of 10 minutes No
Primary Ease of Intubation, as Measured by Number of ETT Redirections To measure the ease of intubation, once the airway structure was visualized with the GlideScope, the number of ETT redirections at the glottis to intubate the trachea was counted by video recordings by the PI. Participants were followed for the duration of intubation, an average of 10 minutes No
Primary Ease of Intubation, as Measured by an Ease of ETT Insertion Score. To measure the ease of intubation, an ease of ETT insertion score was obtained by using a 100 millimeter visual analog scale done by the anesthesia provider doing the intubation. The score of 0 millimeters was the easiest intubation and a score of 100 millimeters was the hardest intubation done by that anesthesia provider. Participants were followed for the duration of intubation, an average of 10 minutes No
See also
  Status Clinical Trial Phase
Completed NCT05746780 - Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
Active, not recruiting NCT03529422 - Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN Phase 2
Completed NCT02126969 - A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN Phase 2
Completed NCT03162731 - Nivolumab, Ipilimumab, and Radiation Therapy in Treating Patients With Stage III-IVB Head and Neck Cancer Early Phase 1
Enrolling by invitation NCT03269396 - Laryngeal Allograft Transplantation N/A
Completed NCT01649973 - Study for Appropriate Operating Table Height for Endotracheal Intubation Under Direct Laryngoscopy N/A
Withdrawn NCT04168671 - CLE During Exercise Testing in Asthma N/A
Completed NCT01321892 - Ex Vivo Multimodal Imaging of Upper Aerodigestive Epithelium N/A
Recruiting NCT05636410 - Ultrasound Assessment of the Larynx and Trachea in the Neonatal Period
Recruiting NCT05565430 - Vocal Cord Responses During Hyperventilation in Normal Individuals and in Mild and Severe Asthmatics.
Completed NCT03109873 - Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer Early Phase 1
Active, not recruiting NCT03737968 - Window of Opportunity Trial of Durvalumab (MEDI4736) or Durvalumab/Tremelimumab as Neoadjuvant Chemotherapy to Identify Immune Dynamics in Surgically Resectable Head and Neck Cancer Patients. Phase 2
Recruiting NCT03109171 - Accuracy of the Sensory Test Using the Laryngopharyngeal Endoscopic Esthesiometer in Obstructive Sleep Apnea N/A
Completed NCT02761239 - Innervation of Human Cricopharyngeal Muscle By Recurrent Laryngeal and External Branch of Superior Laryngeal Nerve N/A
Recruiting NCT05145556 - Teach Intubation by Novices in Anaesthesiology N/A
Completed NCT03030781 - Relationship of Cricoid With the Right and Left Bronchial Diameters in the Pediatric Population Using Three-dimensional Imaging. N/A
Completed NCT03238365 - Window of Opportunity Trial of Nivolumab and Tadalafil in Patients With Squamous Cell Carcinoma of the Head and Neck Early Phase 1
Withdrawn NCT02065128 - The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome N/A
Active, not recruiting NCT03854032 - Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck Phase 2
Active, not recruiting NCT03076281 - Metformin Hydrochloride and Doxycycline in Treating Patients With Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Phase 2